Apr 10, 2023
Daniel Goldman- Amount
- $1,001 to $15,000
- Filed
- May 19, 2023
Congress ticker disclosure profile
As of August 28 at 10:54 AM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference SBRA. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
10
Member filers
3
Disclosed ranges
$178K
Most active member desks
Balanced
Latest trade Apr 10, 2023
Apr 10, 2023
Daniel GoldmanMar 1, 2023
Daniel GoldmanMar 1, 2023
Daniel S. GoldmanNov 8, 2022
Christopher L. JacobsNov 8, 2022
Chris JacobsJun 21, 2022
Christopher L. JacobsFeb 1, 2016
Thomas MacarthurJan 19, 2016
Thomas MacarthurDec 16, 2015
Thomas MacarthurJun 17, 2015
Thomas Macarthur| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| Apr 10, 2023 | Daniel Goldman | Sell | $1,001 to $15,000 | May 19, 2023 | Open card |
| Mar 1, 2023 | Daniel Goldman | Buy | $1,001 to $15,000 | Apr 17, 2023 | Open card |
| Mar 1, 2023 | Daniel S. Goldman | Buy | $1,001 to $15,000 | Apr 17, 2023 | Open card |
| Nov 8, 2022 | Christopher L. Jacobs | Sell | $1,001 to $15,000 | Dec 12, 2022 | Open card |
| Nov 8, 2022 | Chris Jacobs | Sell | $1,001 to $15,000 | Dec 12, 2022 | Open card |
| Jun 21, 2022 | Christopher L. Jacobs | Buy | $15,001 to $50,000 | Jul 28, 2022 | Open card |
| Feb 1, 2016 | Thomas Macarthur | Sell | $15,001 to $50,000 | Mar 3, 2016 | Open card |
| Jan 19, 2016 | Thomas Macarthur | Buy | $15,001 to $50,000 | Feb 6, 2016 | Open card |
| Dec 16, 2015 | Thomas Macarthur | Sell | $15,001 to $50,000 | Jan 6, 2016 | Open card |
| Jun 17, 2015 | Thomas Macarthur | Buy | $1,001 to $15,000 | Jul 11, 2015 | Open card |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 10 of 10 filed rows include disclosed amount ranges (100%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.